Capricor Therapeutics Inc.

CAPR | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.09

+$0.71 (+11.13%)

Nov 2, 2026, 1:38 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Upgrade now ➞

Related Stocks

Company	Yield
DYN Dyne Therapeutics	N/A
EWTX Edgewise Therapeutics	N/A
IONS Ionis Pharmaceuticals	N/A
PEPG PepGen	N/A
PTCT PTC Therapeutics	N/A
SLDB Solid Biosciences	N/A
SRPT Sarepta Therapeutics	N/A
TRDA Entrada Therapeutics	N/A
WVE Wave Life Sciences	N/A

Dividend Rankings ➞

Recent News

3 months ago / benzinga.com
Capricor Therapeutics Shares Dive Before Key Review as FDA Panel Challenges Data
3 months ago / benzinga.com
QUICK SPARK: Capricor Stock Dives — 'Complete Fraud' Says Pharma Bro Martin Shkreli
3 months ago / globenewswire.com
Capricor Comments on Briefing Materials Ahead of July 29 FDA Advisory Committee Meeting for Deramiocel
3 months ago / proactiveinvestors.com
Capricor Therapeutics shares tumble after FDA reviewers raise concerns over Duchenne therapy
3 months ago / benzinga.com
Capricor Therapeutics Stock Plunges After FDA Releases Briefing Documents
3 months ago / reuters.com
FDA staff flags concerns for Capricor's Duchenne heart disease therapy
4 months ago / benzinga.com
What's Going On With Capricor Therapeutics Stock On Friday?
4 months ago / globenewswire.com
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
5 months ago / newsfilecorp.com
Caprock Announces Closing of Private Placement
5 months ago / newsfilecorp.com
Early Warning Press Release - Frank Guillemette Announces Completion of Acquisition of Common Shares of Caprock Mining Corp.